Japanese Pharma Stock News

Thinking about what to do with Okuma stock right now? You are not alone. Whether you are considering starting a new position or simply wondering if it is time to hold or exit, Okuma’s recent performance has likely caught your eye. Over the last year, shares are up 9.0%, riding on years of steady gains, with the stock climbing 38.4% in three years and an impressive 48.0% over five years. Those long-term numbers may look appealing, but you have probably also noticed some short-term bumps. The...

Trying to figure out whether Morinaga&Co is a good buy right now? You are definitely not alone. With so many moving parts in today's markets, it's easy to get caught up in short-term dips and surges. Morinaga&Co’s stock has slid by 3.8% in the last week and is down 4.9% over the past month. Year to date, shares are off 5.2%, adding up to a 7.3% dip over the last twelve months. However, if you take a step back, there is an interesting twist: over the last 3 and 5 years, the stock posted...

Japan Tobacco recently held a board meeting, where it resolved to enter into an absorption-type split contract with Shionogi as part of its ongoing portfolio optimization. In addition, an analyst at JPMorgan upgraded Japan Tobacco’s rating, citing increased market share in the heated tobacco segment and effective reinvestment strategies supporting ongoing gains. We'll now explore how JPMorgan's endorsement of Japan Tobacco's heated tobacco growth ambitions could affect the company's...

Wondering whether to hold tight to your JTEKT shares, make a move, or give this stock a pass? You are not alone. JTEKT has been on quite a ride, capturing plenty of attention on trading screens and in industry discussions. Over the last year, the stock price has surged by 44.6%, with even more dramatic gains if you zoom out to three or five years, at 69.9% and 91.9% respectively. Year-to-date, JTEKT is still up a robust 25.8%. However, recent weeks have brought a slight chill, with the price...

With a price-to-earnings (or "P/E") ratio of 10.6x Nomura Real Estate Holdings, Inc. ( TSE:3231 ) may be sending...

Kaneko Seeds Co., Ltd. ( TSE:1376 ) will pay a dividend of ¥11.00 on the 10th of February. This makes the dividend...

Key Insights The considerable ownership by individual investors in create restaurants holdings indicates that they...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

DaisekiLtd (TSE:9793) has had a rough month with its share price down 9.8%. However, stock prices are usually driven by...

Key Insights The projected fair value for Open Up Group is JP¥1,728 based on 2 Stage Free Cash Flow to Equity Open Up...

With a price-to-earnings (or "P/E") ratio of 10.6x Shoei Yakuhin Co.,Ltd. ( TSE:3537 ) may be sending bullish signals...

Seiwa Electric Mfg. Co., Ltd.'s ( TSE:6748 ) price-to-earnings (or "P/E") ratio of 6.8x might make it look like a...

It is hard to get excited after looking at Kidswell Bio's (TSE:4584) recent performance, when its stock has declined...

Key Insights Insiders appear to have a vested interest in Sun Frontier Fudousan's growth, as seen by their sizeable...

Most readers would already be aware that Yahagi ConstructionLtd's (TSE:1870) stock increased significantly by 18% over...

The Makoto Construction Co,Ltd ( TSE:8995 ) share price has softened a substantial 27% over the previous 30 days...

Nishimatsuya Chain (TSE:7545) reported a net profit margin of 4.4%, a slight dip from last year’s 4.5%, with earnings growing by 2.8% in the past twelve months, just ahead of its five-year average of 2.7% per year. Looking ahead, analysts forecast revenue to rise 4.7% annually, outpacing the broader Japanese market. Earnings are expected to grow 6.2% per year, trailing the market average. Consistent profit and revenue growth, along with the absence of newly identified risks, set the stage for...

Sumitomo Pharma (TSE:4506) is getting more attention from investors after its recent addition to the FTSE All-World Index and a business outlook upgrade from one of the major investment banks. Both events signal a shift in how the market views the company’s future potential. See our latest analysis for Sumitomo Pharma. Sumitomo Pharma’s inclusion in the FTSE All-World Index, combined with a business outlook upgrade, has brought fresh momentum to its shares as investor sentiment improves and...

MGA Entertainment recently announced a partnership with Sanrio to launch the first-ever Bratz x Hello Kitty Collector Dolls, debuting on September 30, 2025. This collaboration brings together two iconic brands and coincides with Hello Kitty's milestone birthday season, appealing to collectors and expanding cross-brand appeal. We'll explore how this high-profile partnership and its potential to attract new fan demographics could impact Sanrio's investment story. Outshine the giants: these 24...

Industrial & Infrastructure Fund Investment Corporation recently completed the repurchase of 7,755 investment units for ¥999.92 million and finalized interest rates for new unsecured, unguaranteed debt financing totaling ¥5.6 billion across three tranches with maturities extending to 2033. This combination of capital management through buybacks and refinancing at fixed rates provides greater clarity into the company’s financial strategy and stability. To see how IIF’s recent completion of...

Onward Holdings (TSE:8016) posted a net profit margin of 4.1%, up from 4% last year, as earnings surged 17.5% year-over-year. The company’s earnings growth over the past five years has averaged an impressive 73% per year; however, the most recent pace is now moderating. With high quality earnings and a price-to-earnings ratio of 9.9x, notably lower than both industry and peer group averages, investors see a solid track record of profitability and strong margins at a discount to peers. See our...

Aohata (TSE:2830) posted a net profit margin of 1.3%, a slight uptick from last year’s 1.2%, with EPS reflecting a notable 13.5% earnings growth over the past year. This marks a stark contrast to the company’s five-year average earnings decline of 24.4% per year. Despite this sharp turnaround, shares trade at an elevated ¥3,695, resulting in a lofty 110.2x Price-To-Earnings Ratio. This is far above the peer and industry averages, raising questions about valuation sustainability in light of...

As global markets navigate a complex landscape marked by cautious Federal Reserve commentary and steady inflation rates, investors are reassessing their strategies amid fluctuating indices and evolving economic indicators. In such an environment, identifying stocks that may be undervalued can present opportunities for those looking to capitalize on discrepancies between market prices and intrinsic value.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...